Erik Manting
Algemeen Directeur bij MENDUS AB
Vermogen: 69 534 $ op 31-05-2024
Actieve functies van Erik Manting
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MENDUS AB | Algemeen Directeur | 16-03-2021 | - |
| Corporate Officer/Principal | - | 16-03-2021 | |
| TRANSCODE THERAPEUTICS, INC. | Directeur/Bestuurslid | 20-12-2020 | - |
| Independent Dir/Board Member | 20-12-2020 | - | |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Directeur/Bestuurslid | 01-03-2019 | - |
Loopbaan van Erik Manting
Eerdere bekende functies van Erik Manting
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Algemeen Directeur | 01-01-2017 | 01-12-2020 |
Kempen & Co. NV
 Kempen & Co. NV Financial ConglomeratesFinance Kempen & Co. NV provides financial services to professional investors. The company's clients include institutional investors, companies, financial institutions, public & semi-public institutions, foundations and high-net-worth private clients. The company was founded in July 1903 by A. J. Kempen and M. D. de Lange and is headquartered in Amsterdam, The Netherlands. | Corporate Officer/Principal | 01-10-2012 | 01-09-2017 |
| Rabo Securities NV | Analyst-Equity | 14-09-2005 | 14-09-2005 |
| Bioentrepreneur BV | Oprichter | 01-09-2017 | - |
Statistieken
Internationaal
| Nederland | 6 |
| Zweden | 2 |
| Verenigde Staten | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
Sectoraal
| Health Technology | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MENDUS AB | Health Technology |
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Rabo Securities NV | Finance |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Health Technology |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Commercial Services |
| Bioentrepreneur BV | |
Kempen & Co. NV
Kempen & Co. NV Financial ConglomeratesFinance Kempen & Co. NV provides financial services to professional investors. The company's clients include institutional investors, companies, financial institutions, public & semi-public institutions, foundations and high-net-worth private clients. The company was founded in July 1903 by A. J. Kempen and M. D. de Lange and is headquartered in Amsterdam, The Netherlands. | Finance |
- Beurs
- Insiders
- Erik Manting
- Ervaring
